비즈니스 윤리를 위한 AI 컨설팅 도구

집

AI 프롬프트 목록

철학/종교

윤리적 의사결정 지원

${:__('collect %s',윤리적 의사결정 지원)}$

철학/종교

기업 운영의 도덕적 딜레마에 대해 공리주의와 의무론에 기반한 균형 잡힌 분석을 제공하여 장기적 가치관과 일치하는 의사결정을 지원합니다.

프롬프트 내용

복사

Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company developing a new drug discovers slight but non-fatal side effects in clinical trial data, while a competitor is about to launch a similar product. Please analyze whether to delay the launch or modify promotional materials by combining utilitarian calculations for the greatest good with deontological adherence to honesty and patient safety principles, and offer a comprehensive strategy balancing business sustainability and moral responsibility, presenting the analysis in a natural, fluent narrative without rigid instructional language.

복사

다음 구체적인 비즈니스 시나리오에 대한 의사결정 조언을 제공하기 위해 기업 윤리 고문으로 행동하십시오: 신약을 개발하는 제약 회사가 임상 시험 데이터에서 경미하지만 치명적이지 않은 부작용 위험을 발견하고 경쟁사가 유사한 제품을 출시하려고 할 때. 최대 다수의 이익에 대한 공리주의적 계산과 정직성과 환자 안전 원칙에 대한 의무론적 고수를 결합하여 출시 지연 또는 홍보 자료 수정 여부를 분석하고, 사업의 지속 가능성과 도덕적 책임의 균형을 맞추는 포괄적인 전략을 제시하십시오. 경직된 지시적 언어를 사용하지 않고 자연스럽고 유창한 서술 방식으로 분석 과정을 제시하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

윤리적 의사결정 지원

Act as a corporate ethics committee to conduct a deep ethical assessment of the following specific business scenario: A major pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Combine the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent to analyze the moral weight of three strategies: concealing information, issuing public warnings, or initiating a recall. Avoid simple right-or-wrong judgments; instead, construct a multi-dimensional evaluation framework including stakeholder impact, legal risks, brand reputation, and social trust. Finally, output an advisory action guide that aims to balance business sustainability with patient welfare, ensuring the decision-making process is transparent and adheres to the highest ethical standards.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, yet a recall would bankrupt the company and lay off thousands. Evaluate the ethical weights of recalling versus not recalling by combining utilitarian calculations for the greatest good with deontological respect for human dignity, and provide a specific action plan that balances social responsibility with corporate survival, focusing on how to build public trust through transparent communication.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the moral dilemma in the following business scenario: A pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Please weigh the benefits of disclosure against the risks of concealment, combining utilitarian consequence assessment with deontological respect for informed consent. Finally, provide a specific action plan that balances patient safety, corporate reputation, and legal compliance, focusing on how to maintain trust through transparent communication while minimizing potential harm.

윤리적 의사결정 지원

Act as a corporate ethics consultant to conduct a deep moral deduction on the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but irreversible neurological side effects with long-term use, yet stopping medication carries higher risks and alternative therapies are less effective. Please analyze the ethical weight of four strategies—disclosing information, adjusting pricing, reformulating, or withdrawing from the market—by balancing utilitarian calculations for the greatest good against deontological adherence to patient知情权 and non-maleficence. Provide a final action recommendation that balances business sustainability with social responsibility, focusing on how to build trust through transparency and patient safety.

윤리적 의사결정 지원

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-listed common drug may cause severe side effects in a very small group of patients with specific genetic profiles, but the recall cost is extremely high and could lead to drug shortages affecting the majority of patients. Please evaluate the moral rationality of three options—full recall, partial recall, or continued sales—by combining the utilitarian principle of maximizing happiness with the deontological obligation to respect individual rights and the duty of honest disclosure. Provide the best course of action that balances the interests of all parties and aligns with corporate social responsibility, focusing on the ethical trade-off logic in the decision-making process.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but predictable side effects with long-term use, yet stopping production would leave millions of dependent patients without basic treatment. Please evaluate whether the drug should be voluntarily recalled by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological duty to honestly inform patients of risks. In your analysis, weigh shareholder interests, patient safety, legal compliance, and social trust, and provide a specific action recommendation that balances ethical responsibility with business sustainability, avoiding abstract theoretical stacking and focusing on the practical execution level of ethical trade-offs.